Skip to main content
Decorative image of the AMR Learning Lounge

Performance of the Reveal Rapid Antibiotic Susceptibility Testing System on Gram-Negative Blood Cultures at a Large Urban Hospital

SUMMARY

Antibiotic susceptibility testing (AST) systems need to be accurate, rapid, affordable and useable for a broad antimicrobial menu to enable widespread clinical adoption. This study by Henry Ford Health System and Specific Diagnostics evaluated its impact on positive blood cultures with Gram-negative organisms in a relatively resistant population to assess its potential for routine clinical use. Specific Diagnostics is a bioMérieux-owned company.

FEATURED EXPERTS

(Lead Author) Linoj Samuel, PhD, Clinical Microbiologist at Henry Ford Health System in Detroit, Michigan


GET STARTED

Read the study at Journal of Clinical Microbiology, an ASM publication.

Read time: 30 minutes


We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.


Global Solutions

VITEK® REVEAL™

The newest addition to our Sepsis Solution, VITEK® REVEAL™ offers rapid AST results to effectively and efficiently manage bloodstream infections.

PUBLISHED BY

Journal of Clinical Microbiology
May 24, 2022


SHARE THIS ARTICLE: